Results for "Understanding Pharmaceutical Distribution"
HDA’s 2026 DMA Award Winner Discusses the Benefits of Cardinal Health’s EDI 852 Quarantine Field Solution
As supply chain stakeholders continue to adapt to Drug Supply Chain Security Act (DSCSA) requirements following a lengthy and technical implementation period, some HDA member companies are discovering that practical tools to improve visibility can make a meaningful difference across the supply chain.
HDA at the Bold Bets Healthcare Summit: Strengthening the Supply Chain for the Future
On June 4, healthcare leaders gathered at the Widehall Bold Bets Healthcare Summit to discuss the opportunities and challenges shaping the industry's future. Sponsored by the HDA, Eli Lilly and BD, the event brought together voices from across government, science and industry to explore topics ranging from artificial intelligence and healthcare affordability to emergency preparedness, innovation and the future of patient care.
HDA Foundation Serialization Survey Shows Slow Progress, Industry Concerns Leading Up to 2023 DSCSA Compliance Deadline
According to the HDA Research Foundation’s latest Serialization Readiness Survey, three-quarters of surveyed pharmaceutical manufacturers anticipate sending 100 percent of Drug Supply Chain Security Act (DSCSA)-required serialized data with shipped products by November 27, 2023 — the deadline to comply with the law.
Creating Successful Public Health Partnerships in the Age of COVID-19
The coronavirus pandemic fostered and underscored the benefits of public-private partnerships as healthcare supply chain companies used their expertise and strengths to support the government’s response to an ongoing health crisis. The Milken Institute’s “2021 Partnering for Patients Forum” explored this topic during a panel discussion entitled, “Reimagining Public Health Partnerships: Lessons Learned from the Pandemic.”